HM
AFTR

Howard Marks’s AfterNext HealthTech Acquisition Corp AFTR Stock Holding History

Howard Marks’s Portfolio AFTR Stock Details AFTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-150,000
Closed -$1.46M – 420
2021
Q4 		$1.46M Buy
+150,000
New +$1.46M 0.02% 279

Other funds holding AFTR

GC
Guggenheim Capital Chicago, Illinois $15.9B AUM 53.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Howard Marks's AFTR Position: Q1 2022 in Review

Howard Marks sold out of AfterNext HealthTech Acquisition Corp (AFTR) in Q1 2022, closing a stake of 150,000 shares — an estimated $1.46M sold.

Howard Marks first reported a position in AFTR in Q4 2021 and held it in 1 quarter. The position peaked at $1.46M in Q4 2021. 34 funds tracked by Wall St. Rank hold AFTR as of Q1 2022.

  • Howard Marks reported no remaining AfterNext HealthTech Acquisition Corp position as of Q1 2022 after selling out during the quarter.
  • Howard Marks sold 150,000 AfterNext HealthTech Acquisition Corp shares in Q1 2022, an estimated $1.46M.
  • Howard Marks first reported a position in AfterNext HealthTech Acquisition Corp in Q4 2021 and held it in 1 quarter.
  • Howard Marks's AfterNext HealthTech Acquisition Corp position peaked at $1.46M in Q4 2021.
  • 34 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp as of Q1 2022.

Based on Oaktree Capital Management's 13F filing for Q1 2022, filed 16 May 2022.